Murlentamab

• CAS Number :

  2058047-65-5

• Target :

  Others|||TGF-beta/Smad

• Related Pathways :

  Others|||Stem Cells

• Purity :

  1

• Bioactivity :

  Murlentamab (GM102) is a humanized anti-AMhRII antibody. Murlentama has potential antitumor activity that induces macrophage-mediated antitumor-dependent cell-mediated cytotoxic effects (ADCC) . Murl can stimulate the pro-inflammatory and anti-tumor internal environment by recruiting, collecting and activating T cells. Murlentama exerts antitumor activity by promoting naive macrophage orientation and promoting tumor-associated macrophage (TAM) reprogramming.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C